Mechanical properties and biomedical application characteristics of degradable polylactic acid-Mg-Ca<sub>3</sub>(PO<sub>4</sub>)<sub>2</sub> three-phase composite.
biomechanical · Level V
Where this comes from
- Record sourced from PubMed, PMID 34736029.
- Also identified by DOI 10.1016/j.jmbbm.2021.104949.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Polylactic acid (PLA), pure magnesium powder, and calcium phosphate powder were used to form a three-phase degradable biomedical composite. The effects of various powder proportions in polylactic acid-Mg-Ca<sub>3</sub>(PO<sub>4</sub>)<sub>2</sub> composites were analyzed through mechanical and biological tests, which revealed that both the tensile and impact strength of the composite increased. Additionally, ductility presented only after a small proportion of powder was added. Hardness slightly increased because of dispersion strengthening. Furthermore, the addition of pure magnesium and calcium phosphate accelerated the degradation rate, and biocompatible salts were generated after degradation, which can improve healing and renewal in bone tissue. None of the composites exhibited cytotoxicity, meeting biological safety requirements. Overall, PLA10M10C (10 wt.% Mg, 10 wt.% Ca<sub>3</sub>(PO<sub>4</sub>)<sub>2</sub>) exhibited superior performance. Accordingly, PLA10M10C can serve as a reference for degradable biomedical material applications in orthopedic implants.
Medical subject headings
- Polyesters